Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome. - Smith MR; Lee H; McGovern F; Fallon MA; Goode M; Zietman AL; Finkelstein JS (Cancer, 2008)